Variables | Univariate in variceal bleeding (n = 195) |  | Multivariat in variceal bleeding (n = 195) |  |
---|---|---|---|---|
Hazard Ratio (95% CI) | P-value | Hazard Ratio (95% CI) | P-value | |
Age (years) | 0.988 (0.964–1.012) | 0.318 |  |  |
Gender (male vs. female) | 1.679 (0.986–2.858) | 0.056 |  |  |
Child-Pugh score | 1.300 (1.201–1.408) | < 0.001 | 1.080 (0.959–1.216) | 0.202 |
MELD (score) | 1.178 (1.107–1254) | < 0.001 | 0.978 (0.889–1.076) | 0.646 |
BMI (kg/m2) | 0.874 (0.749–1.020) | 0.088 |  |  |
BCLC stage, A/B/C/D, n (%) | 3.013 (2.198–4.131) | < 0.001 |  |  |
Maximum tumor size, cm, mean ± SD | 1.132 (1.019–1.257) | 0.021 |  |  |
Multifocal tumor, n (%) | 2.685 (1.581–4.561) | < 0.001 |  |  |
Extent of portal vein tumor thrombus Grade I/ Grade II/ Grade III/Grade IV, n (%) | 1.899(1.584–2.277) | < 0.001 |  |  |
Size of EV ≥ 4 mm/Size of EV < 4 mm, n (%) | 3.097 (1.962–4.887) | < 0.001 |  |  |
Prior overt hepatic encephalopathy, n (%) | 3.932 (2.237–6.913) | < 0.001 | 0.550 (0.238–1.274) | 0.163 |
Ascites, n (%) | 1.156 (0.418–3.199) | 0.779 |  |  |
ALT (IU/L) | 1.002(0.996–1.008) | 0.506 |  |  |
AST (IU/L) | 1.011 (1.003–1.020) | 0.011 | 1.008 (0.997–1.018) | 0.148 |
Prothrombin time (s) | 0.910 (0.780 − 0.061) | 0.228 |  |  |
Serum albumin (g/l) | 1.006 (0.966–1.048) | 0.783 |  |  |
Total bilirubin (µmol/l) | 1.004 (0.998–1.009) | 0.226 |  |  |
Platelet count (×109/mm3) | 0.008 (1.002–1.015) | 0.009 | 1.004 (0.997–1.010) | 0.268 |
HCCPHTIS | 2.277 (1.881–2.757) | < 0.001 | 2.330 (1.728–3.142) | < 0.001 |